Comparative Study of Native or Nano Quercetin on Epigenetic Modification and Nephropathy Biomarkers Post Challenges in Diabetic Hamsters

Soha Shebel Nassar; Huda M. Ismail Abo-Elfadl;

Abstract


Aims: The aim of this study is to examine the regulatory effects of quercetin nanoparticles (QNPs)
compared with native quercetin either with or without metformin against the abnormal molecular
and biochemical pathways that eventually culminate in the pathologic condition clinically known as
diabetic nephropathy (DN) in hamsters
Methodology: After synthesis and characterization of the QNPs, seventy male adult hamsters are
divided as following; G1:healthy control, G2:untreated DN hamsters, G3:DN+metformin
G4:DN+native quercetin, G5:DN+QNPs, G6:DN+native quercetin+ metformin and G7: DN + QNPs
+ metformin.
Results: Our results illustrated that the effect of QNPs + metformin is the most effective in IRS-1
and GLUT-4 gene expression that correlated with inhibition of HDACs which in turn
improved diabetic and nephropathy biomarkers, this effectiveness followed by G6 then
G3 and finally G4 after G5. These results were confirmed by immunohistochemical
examinations. Levels of antioxidant and inflammatory biomarkers also reflected the protective effect
of our treatments.
Conclusion: All tested treatments significantly exhibit renal improvement.


Other data

Title Comparative Study of Native or Nano Quercetin on Epigenetic Modification and Nephropathy Biomarkers Post Challenges in Diabetic Hamsters
Authors Soha Shebel Nassar; Huda M. Ismail Abo-Elfadl 
Keywords Diabetic nephropathy;Quercetin;nano particles;gene expression
Issue Date 29-Jun-2021
Journal Journal of Pharmaceutical Research International 
Volume 33
Issue 33B
Start page 140
End page 153
DOI 10.9734/JPRI/2021/v33i33B31805

Attached Files

File Description SizeFormat Existing users please Login
4.pdf538.39 kBAdobe PDF    Request a copy
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check



Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.